Aspirin Breaks Down Four Times Faster Than Ibuprofen, According To New Bayer Study
Executive Summary
The first-ever 'in vivo' study of blockbuster drug Aspirin reveals that it dissolves four-times faster than ibuprofen and ibuprofen lysine, claims Bayer.
You may also be interested in...
Q4 Consumer Health Earnings Preview: GSK, Bayer, RB, And Sanofi
GSK is looking to close out 2018 strongly as it prepares to launch its Consumer Health JV with Pfizer, while Bayer will be glad to see the back of a tough year. Elsewhere, RB is preparing for life after Rakesh Kapoor and Sanofi is ramping up its push into digital health.
Bayer Slapped With Weighty Fine For Misleading Consumers in Hungary
Advertisements for Bayer's Berocca brand in Hungary were found to be misleading by the national competition watchdog, resulting in a considerable fine for the German group.
Bayer's Consumer Chief Initiates Turnaround Plan In Bid To Return Troubled Business To Growth
Bayer's Consumer Health chief Heiko Schipper is hoping a focus on innovation and a leaner portfolio will help return the business to mid-single-digit growth by 2022. The German firm has identified its North American business as the 'key area to fix'.